DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Aktueller Standort:
>
> This Story


Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Demand on the rise for MR-guided radiotherapy, says new report Compound annual growth rate of 20 percent through 2028

New proton therapy center planned in Russia Investment calls for 7.5 billion rubles to bring greater cancer care to patients

NYC proton facility opens for business $300 million dollar, 140,000 square-foot facility was ten years in the making

Bill aiming to reduce prior authorization delays for cancer treatment introduced in Congress Supporting timely access to care

Roche and GE Healthcare release NAVIFY Tumor Board 2.0 Supports personalized treatment decision-making

Cancer mortality for men, women and children on the decline, says report Decreased by 1.8 percent in men and 1.4 percent in women

FDA okays Philips' MR-only radiotherapy simulator, MRCAT pelvis Create treatment plans for bladder, rectal, anal and cervical cancer

Japanese startup to develop ultra-compact proton therapy system Designed to replace conventional radiotherapy systems

Varian to acquire Cancer Treatment Services International for $283 million Enables production of multidisciplinary solutions

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

Elekta is suing ZAP Surgical
Systems over what it claims is
patent infringement of its rotatable
radiation treatment system

Elekta sues ZAP Surgical Systems, claiming patent infringement

by John R. Fischer , Staff Reporter
Radiotherapy provider Elekta is taking ZAP Surgical Systems to court over allegations of patent infringement, regarding the design of a radiosurgery platform.

The California-based enterprise filed the suit, titled Elekta Limited and Elekta Inc. v. ZAP Surgical Systems, Inc., this month in the United States District Court for the Northern District of California, asserting that the manufacturing, importation, advertising, sale and use of the ZAP-X Gyroscopic Radiosurgery Platforms violates a patent for a rotatable treatment system designed by Elekta.

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs



"Zap Surgical is acting quickly and will defend itself aggressively," said John Adler in a statement to HCB News. "We have engaged with legal counsel and already our team has identified several promising non-infringement and invalidity positions that we are working to develop further."

Elekta Limited is seeking monetary damages with a threefold enhancement for willful infringement, and an injunction to prevent the importing, manufacturing, sale and use of the product in the U.S.

"Elekta is a recognized innovator in radiation-based treatment technologies," said Jonas Bolander, general counsel and executive vice president for Elekta, in a statement. "We invest heavily in the research and development of new and better therapies for patients, and we value and vigorously protect the intellectual property rights that result from such investment. As demonstrated in the past, Elekta will not accept any violation of its intellectual property rights."

Its suit follows the adoption of ZAP Surgical Systems’ radiosurgery platform, which gained FDA clearance in 2017, by Barrow Brain and Spine in Phoenix, Arizona to deliver stereotactic radiotherapy to treat patients with brain tumors. In addition, clinical trials are expected to begin in June in Beijing.

Equipped with self-shielding technology, the solution is designed as an alternative to invasive surgery that delivers high-dose radiation to brain tumors precisely, while protecting normal brain tissue and other organs, such as the eyes. It requires no cement radiation vault to protect operators when in use, saving providers an estimated one to two million dollars.

“It’s like a shaper knife,” Dr. John Adler, founder and CEO of ZAP Surgical Systems and a professor of Neurosurgery at Stanford University, told HCB News at the time of its adoption at Barrow Brain and Spine, noting that the ZAP-X platform is more precise, from more directions, than existing SRS technology. The ZAP-X is also safer because it lets operators record the radiation as it is being administered, he added.

The patent, No. 7,295,648, is one of many granted worldwide and claims priority from GB Patent Application Nos. 0324676.6 and 0325698.9.

Elekta did not respond for comment.

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

E-Mail-Werbung
Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Übersicht
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Gesundheitsdienstleister
Alle Gesundheitsdienstleister-Tools anzeigen
Jobs/Training
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich auf DOTmed bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Servicetechniker
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED